Trial Profile
Evaluation of a New Therapeutic Strategy in Early and Active Relapsing-Remitting Multiple Sclerosis: Induction Treatment With Mitoxantrone Followed by Long-Term Treatment With Interferon-beta1b
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 14 Dec 2011
Price :
$35
*
At a glance
- Drugs Mitoxantrone (Primary) ; Interferon beta-1b
- Indications Multiple sclerosis
- Focus Therapeutic Use
- 21 Jul 2006 New trial record.